×
About 16,565 results

ALLMedicine™ Vasculitis Center

Research & Reviews  5,779 results

Pediatric Behҫet disease: Update in diagnosis and management.
https://doi.org/10.1111/pde.14859
Pediatric Dermatology; Burns E, Cooper E et. al.

Jan 22nd, 2022 - Behҫet disease is a multisystem inflammatory disease and variable vessel vasculitis involving primarily the oral and genital mucosa, skin, and eyes. Diagnosis is challenging due to the lack of a specific diagnostic test and overlap with other auto...

Mitral valve replacement due to Libman-Sacks endocarditis: lower limb cellulitis as a r...
https://doi.org/10.1136/bcr-2021-246078
BMJ Case Reports; Sexton G, McLoughlin J et. al.

Jan 22nd, 2022 - A 56-year-old woman was admitted due to new ulceration and acute digital ischaemia on a background of chronic leg ulcers bilaterally. Vasculitis screening returned strongly positive lupus anticoagulant levels and elevated anticardiolipin antibodie...

Defective STAT5 Activation and Aberrant Expression of BCL6 in Naive CD4 T Cells Enhance...
https://doi.org/10.4049/jimmunol.2001331
Journal of Immunology (Baltimore, Md. : 1950); Kim S, Boehme L et. al.

Jan 19th, 2022 - Granulomatosis with polyangiitis (GPA) is a potentially fatal small vessel vasculitis of unknown etiology, characterized by anti-neutrophil cytoplasmic autoantibodies, chronic inflammation, and granulomatous tissue damage. T cell dysregulation, co...

Granulomatous vasculitis presenting as annular erythema in neurosarcoidosis.
https://doi.org/10.1093/rheumatology/keac033
Rheumatology (Oxford, England); Karakida K, Nunokawa T et. al.

Jan 19th, 2022 - Granulomatous vasculitis presenting as annular erythema in neurosarcoidosis.|2022|Karakida K,Nunokawa T,Chinen N,Komatsu A,|

Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement.
https://doi.org/10.1007/s10067-021-05937-8
Clinical Rheumatology; Delapierre A, Terrier B et. al.

Jan 19th, 2022 - Joint involvement can be observed during the course of adult IgA vasculitis (IgAV). However, clinical picture, prognosis, or pathophysiological data associated with this condition have been overlooked. We aimed to describe the clinical characteris...

see more →

Guidelines  17 results

ACR Appropriateness Criteria® Cerebrovascular Diseases-Aneurysm, Vascular Malformation,...
https://doi.org/10.1016/j.jacr.2021.08.012
Journal of the American College of Radiology : JACR; , Ledbetter LN et. al.

Nov 20th, 2021 - Cerebrovascular disease is a broad topic. This document focuses on the imaging recommendations for the varied clinical scenarios involving intracranial aneurysms, vascular malformations, and vasculitis, which all carry high risk of morbidity and m...

ACR Appropriateness Criteria® Noncerebral Vasculitis.
https://doi.org/10.1016/j.jacr.2021.08.005
Journal of the American College of Radiology : JACR; , Aghayev A et. al.

Nov 20th, 2021 - Noncerebral vasculitis is a wide-range noninfectious inflammatory disorder affecting the vessels. Vasculitides have been categorized based on the vessel size, such as large-vessel vasculitis, medium-vessel vasculitis, and small-vessel vasculitis. ...

Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.
https://doi.org/10.1016/j.kint.2021.05.015
Kidney International; Rovin BH, Adler SG et. al.

Sep 25th, 2021 - The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases is an update to the KDIGO 2012 guideline. The aim is to assist clinicians caring for individuals with glomerulonephritis (G...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/art.41773
Arthritis & Rheumatology (Hoboken, N.J.); Chung SA, Langford CA et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of antineutrophil cytoplasmic antibody-associated vasculitis (AAV), including granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), and eosinophilic...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/art.41776
Arthritis & Rheumatology (Hoboken, N.J.); Chung SA, Gorelik M et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, interv...

see more →

Drugs  139 results see all →

Clinicaltrials.gov  120 results

Zooming in on Cerebral Abnormalities in Severely Affected COVID-19 Patients
https://clinicaltrials.gov/ct2/show/NCT05197296

Jan 19th, 2022 - Brain injury is one of the complications in COVID-19 intensive care unit (ICU) survivors, though the precise underlying mechanism is unclear. It is likely caused by a combination of prolonged hypoxia, a massive systemic inflammatory response, dire...

Efficacy and Safety of Rituximab in the Treatment of Good Prognosis Microscopic Polyangiitis
https://clinicaltrials.gov/ct2/show/NCT03920722

Jan 11th, 2022 - Microscopic polyangiitis (MPA), is a small-sized vessel necrotizing vasculitis associated with anti-neutrophils cytoplasmic antibody (ANCA). Treatment of ANCA associated vasculitis (AAV) was previously based on glucocorticoids (GC) and cyclophosph...

Statins Study in Kawasaki Disease Children With Coronary Artery Abnormalities
https://clinicaltrials.gov/ct2/show/NCT03915795

Jan 11th, 2022 - Kawasaki disease (KD) is an acute self-limited vasculitis and occurs almost exclusively in childhood. It predominantly affects medium-sized arteries, most commonly the coronary arteries. Although the use of intravenous immunoglobulin (IVIG) has ob...

Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura
https://clinicaltrials.gov/ct2/show/NCT03647852

Jan 10th, 2022 - IgA vasculitis is relatively common in children,especially in Asian countries. Abdominal manifestation could be severe, including bleeding, pancreatitis,appendicitis and intestinal intussusception. Delayed diagnosis could be fatal and cause severe...

The Pathogenesis and Natural History of Sjogren s Syndrome
https://clinicaltrials.gov/ct2/show/NCT01425892

Jan 5th, 2022 - BACKGROUND Sj(SqrRoot)(Delta)gren s syndrome (SS) is an autoimmune disease characterized by chronic inflammation involving the exocrine glands. Salivary and lacrimal glands are predominantly affected leading to dry mouth and dry eyes but other exo...

see more →

News  551 results

Reassurance on COVID Vax Safety in Rheumatic Diseases
https://www.medpagetoday.com/rheumatology/generalrheumatology/96482

Jan 4th, 2022 - Registry data collected in 30 European countries indicate that reactions to COVID-19 vaccines were no different in individuals with inflammatory rheumatic illnesses versus non-inflammatory conditions such as osteoporosis, researchers said. In phys...

Immune Checkpoint Inhibitors Correlate With Specific Neurologic Events
https://www.onclive.com/view/immune-checkpoint-inhibitors-correlate-with-specific-neurologic-events

Jan 3rd, 2022 - Use of immune checkpoint inhibitors (ICIs) was clearly associated with higher incidences of specific neurologic toxicities in a broad-based retrospective pharmacovigilance study, and clinicians need to monitor for these immune-related adverse even...

Large Leg Ulcers After Swimming in the Ocean
https://www.mdedge.com/dermatology/article/249007/infectious-diseases/large-leg-ulcers-after-swimming-ocean
Paul Macklis, MD, MS, Cory Pettit, MD et. al.

Nov 22nd, 2021 - The Diagnosis: Vibrio vulnificus Infection At the initial presentation, the differential diagnosis included infectious processes such as bacterial or angioinvasive fungal infections or an inflammatory process such as pyoderma gangrenosum. Blood cu.

Rituximab, Cyclophosphamide Similar for Inducing EGPA Remission
https://www.medscape.com/viewarticle/963134

Nov 17th, 2021 - Rituximab didn't perform any worse or better at inducing remission after a year in patients with eosinophilic granulomatosis with polyangiitis (EGPA) than did conventional treatment with cyclophosphamide in the phase 3 REOVAS trial conducted in Fr...

ADVOCATE: Avacopan Shows Renal Benefits in ANCA Vasculitis
https://www.medscape.com/viewarticle/963050

Nov 16th, 2021 - Dr David R.W. Jayne Treatment of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis and renal disease with the oral C5a receptor inhibitor avacopan (Tavneos, ChemoCentryx) provides significant recovery of kidney function compared...

see more →

Patient Education  20 results see all →